– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of August 2020.
M&A is back and the velocity of the rebound has outpaced all expectations. The recovery quickly worked its way across the spectrum from large to small-cap, beginning with the larger cap NASDAQ rally of nearly 80% from lows in late March (only to soften in recent days), followed by multi-billion
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Why EHR Interoperability is Critical for Telehealth
Telehealth has recently taken off as a way to prevent the spread of the novel coronavirus, but even though telehealth has been around for several years, clinics had difficulty adopting it pre-COVID-19. This caused clinics to not view telehealth as a viable option, and it was often seen as a last resort approach to healthcare.
As reducing the spread of COVID-19 became paramount, Medicare and Medicaid were forced to develop telehealth service codes, and clinics were tasked with finding an
Read More
Castor Raises $12M to Advance COVID-19 Research Through Clinical Trial and Data Automation
What You Should Know:
- Castor raises $12M in Series A funding to further their
support for COVID-19 research through clinical trial and data automation.
- With 4,000 live studies and 2,000,000 enrolled patients
across 90 countries, Castor will use the funding to further invest in enabling
patient-centric, data-powered clinical trials.
Castor, a Hoboken,
New Jersey startup using automation and data reuse to simplify the entire
clinical trial process, announced $12M in Series A
Read More
Mission Bio Lands $70M to Expand Cancer Therapies With Single-Cell Multi-Omics Platform
What You Should Know:
- Mission Bio raises $70 million in Series C funding led by
Novo Growth to accelerate the development of cancer therapies with single-cell multi-omics.
- Mission Bio’s Tapestri Platform, the first single-cell platform capable of detecting DNA and protein changes simultaneously, gives a profound insight into the mutations that drive disease to accelerate the development of novel treatments and save patient lives.
Mission Bio,
Inc., a South San Francisco,
Read More
FDA, Syapse Expand Research to Generate Real-World Data Related to COVID-19 and Cancer
What You Should Know:
The FDA and Syapse announce research collaboration expansion
to address urgent public health challenges including supporting FDA’s goal of
rapid understanding of COVID-19.
As part of the research, Syapse is partnering with FDA’s
Oncology Center of Excellence to investigate methods to derive RWD from
multiple sources including electronic health records, registries and molecular
data
Syapse, a real-world
evidence company accelerating the delivery of precision
Read More
AstraZeneca, Eko Collaborate to Advance Innovation Around Heart Failure
What You Should Know:
- Eko today announced a global collaboration with
AstraZeneca to accelerate the development of digital health tools for the
earlier screening of cardiovascular diseases, including heart failure.
- Through the collaboration, AstraZeneca and Eko will explore accelerating the development of Eko algorithms, enhancing clinical trials with Eko technology, and potentially building new heart failure detection solutions.
Eko, a digital health company
Read More
Ciox Health Acquires Biomedical NLP Company Medal
What You Should Know:
- Ciox Health has acquired Medal, Inc., a biomedical
Natural Language Processing (biomed-NLP) technology company.
- The acquisition will lead Ciox to better and more
quickly enable real-world data in support of research that advances patient
care.
Ciox
Health, a leading health technology company, today announced its acquisition
of San Francisco-based biomedical Natural Language Processing (biomed-NLP)
technology company, Medal, Inc., a leader
in
Read More
W2O Acquires Discern Health to Strengthen Value-Based Care Capabilities
What You Should Know:
- W2O announced today the acquisition of Discern Health, a leading healthcare consultancy based in Washington, DC, and Baltimore, to strengthen its strategic capabilities in assisting clients with critical healthcare policy trends and value-based reimbursement models.
- Discern Health brings experts with decades of experience in quality, health care measurement, and payment models to W2O’s analytics-driven, technology-enabled marketing and communications solutions.
Read More
COVID-19 Has Permanently Shifted Patient Behavior Towards Virtual Care
What You Should Know:
- The COVID-19 crisis has significantly impacted the
patient care paradigm, and the ripple effects have altered patient behaviors
and expectations, requiring a significant change in how life sciences companies
engage with and support patients
- Accenture surveyed 2700 patients about changes in care
during COVID-19 and found a major shift to virtual care, which patients
embraced.
- Virtual care is here to stay and can be an integral
part of the patient experience
Read More
Scripps Research, Repurpose.AI Partner to Develop COVID-19 Therapeutics
What You Should Know:
- Repurpose.AI, has partnered with Scripps Research to
discover drug candidates that may be repurposed to treat COVID-19.
- The partnership will leverage Repurpose.AI's ActivPred
AI Drug Discovery Platform, an unbiased drug, target, and disease agnostic
digital chemistry engine, to discover drug candidates to treat COVID-19.
Scripps Research is
teaming up with Repurpose.AI, an AI
drug discovery company to develop COVID-19 therapeutics. The
Read More
